Cargando…

Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study

Parkinson’s disease (PD) is characterized by the degeneration of the dopaminergic nigrostriatal neurons and the presence of Lewy bodies (LB) and Lewy neurites (LN) mainly composed of α-synuclein. By using the in situ proximity ligation assay (PLA), which allows for the visualization of protein-prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Longhena, Francesca, Faustini, Gaia, Missale, Cristina, Pizzi, Marina, Bellucci, Arianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032099/
https://www.ncbi.nlm.nih.gov/pubmed/29848975
http://dx.doi.org/10.3390/ijms19061611
_version_ 1783337439354421248
author Longhena, Francesca
Faustini, Gaia
Missale, Cristina
Pizzi, Marina
Bellucci, Arianna
author_facet Longhena, Francesca
Faustini, Gaia
Missale, Cristina
Pizzi, Marina
Bellucci, Arianna
author_sort Longhena, Francesca
collection PubMed
description Parkinson’s disease (PD) is characterized by the degeneration of the dopaminergic nigrostriatal neurons and the presence of Lewy bodies (LB) and Lewy neurites (LN) mainly composed of α-synuclein. By using the in situ proximity ligation assay (PLA), which allows for the visualization of protein-protein interactions in tissues to detect dopamine transporter (DAT)/α-synuclein complexes, we previously described that these are markedly redistributed in the striatum of human α-synuclein transgenic mice at the phenotypic stage, showing dopamine (DA) release impairment without a DAT drop and motor symptoms. Here, we used the in situ PLA to investigate DAT/α-synuclein complexes in the caudate putamen of PD patients and age-matched controls. They were found to be redistributed and showed an increased size in PD patients, where we observed several neuropil-like and neuritic-like PLA-positive structures. In the PD brains, DAT immunolabeling showed a pattern similar to that of in situ PLA in areas with abundant α-synuclein neuropathology. This notwithstanding, the in situ PLA signal was only partially retracing DAT or α-synuclein immunolabeling, suggesting that a large amount of complexes may have been lost along with the degeneration process. These findings reveal a DAT/α-synuclein neuropathological signature in PD and hint that synaptic alterations involving striatal DAT may derive from α-synuclein aggregation.
format Online
Article
Text
id pubmed-6032099
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60320992018-07-13 Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study Longhena, Francesca Faustini, Gaia Missale, Cristina Pizzi, Marina Bellucci, Arianna Int J Mol Sci Communication Parkinson’s disease (PD) is characterized by the degeneration of the dopaminergic nigrostriatal neurons and the presence of Lewy bodies (LB) and Lewy neurites (LN) mainly composed of α-synuclein. By using the in situ proximity ligation assay (PLA), which allows for the visualization of protein-protein interactions in tissues to detect dopamine transporter (DAT)/α-synuclein complexes, we previously described that these are markedly redistributed in the striatum of human α-synuclein transgenic mice at the phenotypic stage, showing dopamine (DA) release impairment without a DAT drop and motor symptoms. Here, we used the in situ PLA to investigate DAT/α-synuclein complexes in the caudate putamen of PD patients and age-matched controls. They were found to be redistributed and showed an increased size in PD patients, where we observed several neuropil-like and neuritic-like PLA-positive structures. In the PD brains, DAT immunolabeling showed a pattern similar to that of in situ PLA in areas with abundant α-synuclein neuropathology. This notwithstanding, the in situ PLA signal was only partially retracing DAT or α-synuclein immunolabeling, suggesting that a large amount of complexes may have been lost along with the degeneration process. These findings reveal a DAT/α-synuclein neuropathological signature in PD and hint that synaptic alterations involving striatal DAT may derive from α-synuclein aggregation. MDPI 2018-05-30 /pmc/articles/PMC6032099/ /pubmed/29848975 http://dx.doi.org/10.3390/ijms19061611 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Longhena, Francesca
Faustini, Gaia
Missale, Cristina
Pizzi, Marina
Bellucci, Arianna
Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study
title Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study
title_full Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study
title_fullStr Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study
title_full_unstemmed Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study
title_short Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study
title_sort dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of parkinson’s disease: an in situ proximity ligation assay study
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032099/
https://www.ncbi.nlm.nih.gov/pubmed/29848975
http://dx.doi.org/10.3390/ijms19061611
work_keys_str_mv AT longhenafrancesca dopaminetransporterasynucleincomplexesarealteredinthepostmortemcaudateputamenofparkinsonsdiseaseaninsituproximityligationassaystudy
AT faustinigaia dopaminetransporterasynucleincomplexesarealteredinthepostmortemcaudateputamenofparkinsonsdiseaseaninsituproximityligationassaystudy
AT missalecristina dopaminetransporterasynucleincomplexesarealteredinthepostmortemcaudateputamenofparkinsonsdiseaseaninsituproximityligationassaystudy
AT pizzimarina dopaminetransporterasynucleincomplexesarealteredinthepostmortemcaudateputamenofparkinsonsdiseaseaninsituproximityligationassaystudy
AT bellucciarianna dopaminetransporterasynucleincomplexesarealteredinthepostmortemcaudateputamenofparkinsonsdiseaseaninsituproximityligationassaystudy